Galapagos NV (NASDAQ:GLPG)

55.33
Delayed Data
As of Sep 16
 -0.17 / -0.31%
Today’s Change
54.55
Today|||52-Week Range
148.68
-44.10%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$3.8B

Company Description

Galapagos NV is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. It operates through the Research & Development and Fee-for-Services segment. The company was founded by Onno van de Stolpe, Rudi Pauwels, and Helmuth van Es on June 30, 1999 and is headquartered in Mechelen, Belgium.

Contact Information

Galapagos NV
Industriepark Mechelen Noord
Mechelen Brussels Region 2800
P:(321) 534-2900
Investor Relations:
(781) 460-1784

Employees

Shareholders

Other institutional7.02%
Mutual fund holders4.20%
Individual stakeholders--

Top Executives

Onno van de StolpeChief Executive Officer
Bart FiliusPresident & Chief Operating Officer
Piet WigerinckChief Scientific Officer
Walid Abi-SaabChief Medical Officer
Andre HoekemaChief Business Officer